Clinical trials recruiting for Progression
5
Recruiting trials
0
US states with sites
3
Countries
20%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Creating CTV for primary tumor | 1 |
| Etoposide + carboplatin; Etoposide + cisplatin | 1 |
| Everolimus 5 MG | 1 |
| prophylactic cranial irradiation (PCI) | 1 |
Self-screener
Recruiting trials
- A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
- Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China
- Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
- Liver Disease and Other Systemic Diseases
- Omitting CTV for Primary Tumor in LS-SCLC
Related conditions
Trials recruiting for Progression often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Treatment Outcome 6Screening 5SCLC, Limited Stage 7Radiotherapy Side Effect 16Pancreatic cancer 870Neuroendocrine Tumors 25Neuroendocrine Tumor of Pancreas 3NASH 218Liver Diseases 8
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Progression trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.